AnkitAjitDesaiMDFAHA
Cardiology • Indianapolis, INEchocardiography, Vascular Medicine, Cardiovascular Disease Genetics
Professor, Medicine, Indiana University, Indianapolis, IN
Overview of Dr. Desai
Dr. Ankit Desai is a cardiologist in Indianapolis, IN and is affiliated with Indiana University Health University Hospital. He received his medical degree from University of Illinois College of Medicine and has been in practice 14 years. He also speaks multiple languages, including English, Gujarati, Hindi, and Spanish. He specializes in adult heart disease, pulmonary vascular medicine, sickle cell disease, and cardiovascular genetics and is experienced in pulmonary hypertension, sickle-cell anemia, and medical genetics.
Office
1801 N Senate Blvd
# Sutie
Indianapolis, IN 46202Fax+1 317-962-9657
Education & Training
University of ChicagoFellowship, Cardiovascular Disease, 2008 - 2010
California Pacific Medical CenterResidency, Internal Medicine, 2003 - 2006
University of Illinois College of MedicineClass of 2003
Certifications & Licensure
IN State Medical License 2018 - 2025
AZ State Medical License 2014 - 2020
IL State Medical License 2006 - 2014
CA State Medical License 2003 - 2006- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 30 citationsHemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension.Olga Rafikova, Elissa R Williams, Matthew L. McBride, Marina A. Zemskova, Anup Srivastava
American Journal of Respiratory Cell and Molecular Biology. 2018-08-31 - 22 citationsBiological heterogeneity in idiopathic pulmonary arterial hypertension identified through unsupervised transcriptomic profiling of whole blood.Sokratis Kariotis, Emmanuel Jammeh, Emilia M Swietlik, Josephine A Pickworth, Christopher J Rhodes
Nature Communications. 2021-12-07 - 35 citationsWhole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.Christopher J. Rhodes, Pablo Otero-Núñez, John Wharton, Emilia M. Swietlik, Sokratis Kariotis
American Journal of Respiratory and Critical Care Medicine. 2020-04-30
Press Mentions
New Insights and Potential Treatments for Pulmonary HypertensionAugust 21st, 2024- Beta Blocker Used to Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell CardiomyopathyJanuary 5th, 2024
- Beta Blocker Used To Treat Heart Problems and Other Medical Concerns Could Be New Treatment for Sickle Cell CardiomyopathyJanuary 17th, 2024
Grant Support
- Sickle cell diseaseNHLBI2017–2022
Professional Memberships
- Fellow
- Fellow
- Member
- Pulmonary Hypertension AssociationScientific Leadership Council Member
- Member
- Pulmonary hypertension breakthrough initiativeMember
Other Languages
- Gujarati, Hindi, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
